Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayesian network meta-analysis

BACKGROUND: There are no head-to-head comparisons evaluating the efficacy of the main polychemotherapy regimens used for patients with pancreatic cancer in the adjuvant setting. We aimed to describe the relative efficacy of modified FOLFIRINOX (mFOLFIRINOX), gemcitabine plus capecitabine (GEM-CAP) a...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jesus, Victor Hugo Fonseca, Riechelmann, Rachel P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426008/
https://www.ncbi.nlm.nih.gov/pubmed/34567261
http://dx.doi.org/10.3332/ecancer.2021.1276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426008/
https://www.ncbi.nlm.nih.gov/pubmed/34567261
http://dx.doi.org/10.3332/ecancer.2021.1276

Ejemplares similares